Breast Health
All Breast Health articles
566 articles · showing 271–300
U.S. Government Halts Study on Hormone Replacement Therapy Due to Breast Cancer Risk (dateline August 4, 2002)
A large clinical trial designed to learn the true benefits and risks of hormone replacement therapy (HRT) was stopped early after U.S.
Study: Heat May Be Effective at Treating Breast Cancer (dateline July 24, 2002)
Researchers at Duke University Medical Center are experimenting with a novel way to treat breast cancer that involves heating the tumor while the breast lies in a pool of water.
Large Analysis Finds Sentinel Lymph Node Biopsy Effective for Staging Breast Cancer (dateline July 11, 2002)
A recent study of surgeons from 42 institutions finds that the sentinel lymph node biopsy procedure is effective at determining whether breast cancer has spread to the lymph nodes.
Report Finds Fewer Cancer Deaths Among Americans, But Predict Increase in Near Future (dateline July 9, 2002)
Deaths from cancer continue to decrease in the United States, according to a new report published in the journal, Cancer. The research is based on 1999 and marks a trend that was first reported four years earlier.
U.S. FDA Approves Faslodex for Advanced Breast Cancer (dateline July 8, 2002)
The U.S. Food and Drug Administration recently approved the drug Faslodex (generic name, fulvestrant) to help treat advanced breast cancer.
Study: Identical Twins of Breast Cancer Patients Face High Risk for the Disease (dateline June 25, 2002)
Identical twins of women with breast cancer are three times more likely to develop the disease themselves compared to other women, according to a newly released analysis by a British researcher.
FDA Approves MammoSite Internal Radiation Therapy as New Breast Cancer Treatment Option (dateline June 24, 2002)
The U.S. Food and Drug Administration (FDA) has approved the MammoSite system to deliver internal beam radiation to breast cancer patients after the surgical removel of a breast lump (lumpectomy).
Study: PET Scan Useful in Detecting Breast Cancer Recurrences (dateline June 23, 2002)
A new study suggests that the PET scan may be more beneficial in determining whether breast cancer has returned after treatment than conventional imaging tests, such as mammography, CT scan, or ultrasound.
Medicare Announces New Coverage of Image-Guided Breast Biopsies (dateline June 5, 2002)
The U.S. government has announced that Medicare will begin covering image-guided breast biopsies for breast abnormalities that can be felt by hand (i.e., palpable breast lesions).
Rate of U.S. Breast Cancer Research Stamp Raised (dateline June 4, 2002)
The United States Postal Service recently announced that it has raised the price of its breast cancer research semi-postal stamp from 40 cents to 45 cents, effective March 23, 2002.
ATM Gene Found to Have Role in Frequent Breast Cancer Cases Among Family Members (dateline May 21, 2002)
In recent years, breast cancer research has focused largely on genetic causes for the disease. In 1994, researchers discovered that changes to two genes, BRCA1 (breast cancer gene 1) and/or BRCA2 (breast cancer gene 2), increase a woman's risk of developing breast cancer.
Florida Legislators Approve Special Breast Cancer License Plate to Support Research (dateline May 16, 2002)
A special End Breast Cancer license plate will soon be available to Florida residents, be available to Florida residents, thanks to the efforts of the Florida Breast Cancer Coalition.
Researchers Find Another Gene Associated with Breast Cancer Risk (dateline May 12, 2002)
Researchers have identified another gene that, when mutated, may increase a woman's chance of developing breast cancer. When functioning normally, the CHEK2 gene helps repair damage to DNA.
Another Study Finds Higher Breast Cancer Risk Among Women Who Use Hormone Replacement Therapy for Five Years or Longer (dateline April 30, 2002)
A new study published in the Journal of the American Medical Association shows that using hormone replacement therapy (HRT) for a period of five years (or more) increases a woman's risk of developing breast cancer.
Study Offers New Theory About Aggressive Breast Cancer in African-American Women (dateline April 29, 2002)
Surveys find that African-American women are three times more likely to develop aggressive-type breast cancers and significantly more likely to die from breast cancer than women of other ethnicities.
Study Finds Radiologists Who Read High Number of Mammograms are More Likely to Accurately Detect Breast Cancer (dateline April 17, 2002)
In a study published in the Journal of the National Cancer Institute, researchers found that radiologists who read a large number of mammograms (around 5,000) per year are significantly more likely to accurately detect breast cancer, compared to those physicians who read relatively few mammograms.
NCCN Updates its Breast Cancer Treatment Guidelines for Physicians (dateline April 11, 2002)
At its seventh annual meeting, the National Comprehensive Cancer Network (NCCN) announced that it has updated its Breast Cancer Treatment Practice Guidelines for physicians, nurses, and other healthcare professionals.
More Evidence: Alcohol Increases Breast Cancer Risk (dateline March 31, 2002)
A new study adds to a growing body of evidence that finds that alcohol consumption increases the risk of breast cancer, especially in post-menopausal women.
Researchers Find Education Level/Income Increase Risk of Advanced Breast Cancer Diagnosis (dateline March 30, 2002)
A new study adds to mounting evidence that women with lower incomes and less education are more likely to be diagnosed with advanced breast cancer than women with higher socioeconomic standings.
Cancer Panel Says Mammography May Not Prevent Breast Cancer Deaths, U.S. Government Adhere to Screening Guidelines (dateline March 7, 2002)
An announcement by a scientific board at the National Cancer Institute (NCI) in January 2002 has raised questions about the benefits of mammography in helping to prevent breast cancer deaths.
Researchers Investigate Combination Herceptin/Iressa Treatment for Breast Cancer Patients (dateline February 28, 2002)
The results of a preliminary study find that combining the drugs Herceptin and Iressa may be effective in treating some breast cancer cases. Both drugs work by targeting certain growth factors on the surface of breast cancer cells, which are present in moderate or high amounts in some patients.
Study: Genetic Analysis Helps Determine Which Breast Cancer Patients Need Supplemental Treatments (dateline February 27, 2002)
Between 70% and 91% of breast cancer patients undergo additional treatments, such as chemotherapy, after breast cancer surgery, according to an editorial in the journal, Nature.
Researchers Explore Alternatives to Surgery, Chemotherapy, and/or Radiation for Localized Breast Cancer (dateline February 25, 2002)
Women who are diagnosed with localized breast cancer, cancer that has not spread past the breast, typically undergo surgery and either chemotherapy or radiation as treatment for their disease.
Experts Issue Clinical Guidelines for Ductal Lavage (dateline February 13, 2002)
A group of breast cancer experts has published the first clinical guidelines for using ductal lavage to test for suspicious cellular changes in women at high risk for breast cancer.
Study Finds Many Women Over 40 Do Not Get Annual Mammograms (dateline February 12, 2002)
Despite the increased focus on mammography from non-profit organizations, healthcare professionals, and the media, a new study finds that many women who should be getting yearly screening mammograms are still not doing so.
Researchers Investigate Quality of Life of Breast Cancer Patients After Chemotherapy, Tamoxifen (dateline February 6, 2002)
While breast cancer patients are the largest group of female cancer survivors, researchers know little about their quality of life after treatment. Therefore, Dr. Patricia A.
Raloxifene Shows More Promise in Preventing Breast Cancer (dateline February 5, 2002)
Results of another study have shown that the osteoporosis drug raloxifene (brand name, Evista) may help prevent breast cancer in women at high risk for the disease.
New Shower Kit Helps Remind Women to Perform Monthly Breast Self-Exams (dateline January 25, 2002)
Photo courtesy of First BaSE. To encourage women 20 years of age and older to perform monthly breast self-exams, First BaSE for Women has developed a unique Breast Self-Exam Shower Kit that contains 12 small bath gels—one to use for each monthly breast exam.
Researchers Investigate Strategy to Prevent Resistance to Herceptin in Breast Cancer Patients (dateline January 16, 2002)
While the introduction of the drug Herceptin (generic name, trastuzumab) has been seen as a major advance in the treatment of advanced breast cancer, many breast cancer patients become resistant to the drug in approximately one year.
Update: Study Finds Soft Pad Reduces Discomfort During Mammography (dateline January 15, 2002)
Courtesy of BioLucent, Inc. A study of Swedish and American women presented at the annual meeting of the Radiological Society of North America (RSNA) finds that a new pad consisting of a soft-form cushion helps reduce discomfort associated with mammography.